Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer Preclinical evaluation of kallikrein related peptidase 2 targeting
Popular Abstract in Swedish Prostatacancer är Sveriges vanligaste cancersjukdom bland män. Många av de som diagnosticeras med prostatacancer får inga besvär men cirka 2400 män dör årligen av sjukdomen. Det finns flera behandlingsmetoder mot prostatacancer, men för kastrationsresistent prostatacancer, en avancerad form av prostatacancer, finns idag ingen botande behandling. Det utvecklas dock allt Prostate cancer is one of the major causes of cancer related deaths in men in Europe and the United States. In this doctoral thesis, radioimmunoimaging and -therapy of prostate cancer was investigated pre-clinically by targeting the human kallikrein-related peptidase 2 (hK2) with radiolabelled monoclonal antibodies. hK2 is an antigen that is over-expressed in prostatic neoplasms and is closely rel
